Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical…
The VenusP-Valve PROTEUS STUDY, abbreviated from Evaluation of the PerfoRmance Of The VEnUsP-Valve System in Patients with Native Right Ventricular Outflow Tract (RVOT) Dysfunction, is a prospective multi-center non-randomized interventional study in patients with RVOT disorders comorbid with moderate or greater pulmonary regurgitation. With a target enrollment of 60 subjects, data from this trial will support VenusP-Valve's registration with the U.S. FDA and Japanese Pharmaceuticals and Medical…
PR Newswire
14/06/2024
RAMSAY SANTE :Cosem medical centers takeover
PRESS RELEASEParis, June 14 th2024 Ramsay Santé sustains the local healthcare offering, in sector 1, for more than one million patients, by taking over 11 Cosem multidisciplinary medical centres Ramsay Santé, the European leader in private hospitalization and primary care, announces the takeover of 11 Cosem medical centres.Ramsay Santé's offer covers the existing Cosem centres in Paris, Evry, Caen, Orléans, and Marseille, which care for over 1 million patients annually in...
Nasdaq GlobeNewswire
14/06/2024
Askel Healthcare to Present First Clinical Trial Results of Its COPLA® Knee…
Key Findings from the Pilot Trial Based on the Interim Report with the first 10 Subjects at the 6-Month Follow-Up: Key Findings from the Pilot Trial Based on the Interim Report with the first 10 Subjects at the 6-Month Follow-Up: "Cartilage defects are prevalent, particularly among athletes, and existing treatments are often unreliable. The initial results with COPLA® are impressive, showing promise for active patients by enabling early weight-bearing, swift rehabilitation, and a quick...
PR Newswire
14/06/2024
Casino Group enters into exclusive negotiations with Auchan Retail France and…
Casino Group enters into exclusive negotiations with Auchan Retail France and Rocca with a view to selling its Corsican subsidiary Codim 2 Paris, 14 June 2024The Casino group announces that it has entered into exclusive negotiations with Auchan Retail France and Rocca with a view to selling its subsidiary Codim 2 which operates in Corsica 4 hypermarkets, 9 supermarkets, 3 cash & carries and 2 drive-throughs, having achieved a turnover excluding taxes of 332 million euros in 2023...
Nasdaq GlobeNewswire
14/06/2024
The Enterprise Court of Nivelles approves the BioSenic restructuring plan
PRESS RELEASE – PRIVILEGED INFORMATIONMont-Saint-Guibert, Belgium, June 14, 2024 7.00am CEST –BioSenic(Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases, as well as cell repair, announces that it has received the homologation judgment for the restructuring plan filed with the Enterprise Court of Nivelles. This homologation judgment makes the plan binding on all deferred creditors, and the measures provided...
Nasdaq GlobeNewswire
14/06/2024
Modern Meadow and Earthletica Announce World's First Sustainable Collaboration…
NUTLEY, N.J. and SYDNEY, June 13, 2024 /PRNewswire/ -- Modern Meadow, a creator of innovative, environmentally-friendly biomaterials whose mission is to enable the world to transition to sustainable materials, and Earthletica, an Australian-based company focused on sustainable and high-performance activewear, today announced their collaboration on the Bronte Jacket, named in recognition of competitive swimmer and dual Olympic gold medalist and world champion, Bronte Campbell OAM. This…
PR Newswire
14/06/2024
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Shareholders approve all proposed resolutionsEINDHOVEN, the Netherlands, June13, 2024(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces all proposed...
Nasdaq GlobeNewswire
13/06/2024
Global Artificial Blood Vessels Market to Surpass 3 Billion Mark by 2030 |…
Key Takeaways from the Artificial Blood Vessels Market Report Key Takeaways from the Artificial Blood Vessels Market Report To read more about the latest highlights related to the artificial blood vessels market, get a snapshot of the key highlights entailed in theGlobal Artificial Blood Vessels Market Report Artificial Blood Vessels Overview Artificial blood vessels, often crafted from biocompatible materials like polymers or metals, represent a groundbreaking innovation in...
PR Newswire
13/06/2024
Physical Therapy Supplies Market Poised for USD 27.1 Billion by 2034, Driven by…
Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-2241 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-2241 Physical therapy equipment is used to enhance mobility, build strength, support healing, and preserve general health through various means. Having personal equipment during physical therapy provides patients with...
PR Newswire
13/06/2024
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as…
Disclosure of Share Capital and Voting Rights Outstandingas of May 31, 2024(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Charenton-le-Pont, France (June 13, 2024 - 6:00 pm)– As of May 31, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down...
Nasdaq GlobeNewswire
13/06/2024
Osteotec announces strategic collaboration with Additive Surgical, bringing…
Established in 2020, Additive Surgical is the first company in Australia to offer off-the-shelf 3D-printed titanium spinal implants. After years of research and development the portfolio features proprietary PorOssity™ technology, featuring intricate biomimetic lattices and targeted porosity that promote bone growth—capabilities previously unattainable through traditional manufacturing methods. Established in 2020, Additive Surgical is the first company inAustraliato offer off-the-shelf...
PR Newswire
13/06/2024
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of…
Company announcement – No. 31 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, June 13, 2024–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 2,750 divided into 2,750 new shares with a nominal value of DKK 1 each...
Nasdaq GlobeNewswire
13/06/2024
Annual general meeting has been held in SciBase Holding AB (publ)
Information regarding the newly elected board members' education, experience, assignments and independence can be found on the Company's website https://investors.scibase.se/en/governance/annual-general-meeting. Information regarding the newly elected board members' education, experience, assignments and independence can be found on the Company's websitehttps://investors.scibase.se/en/governance/annual-general-meeting. For more information, please contact: Pia Renaudin, CEO SciBase...
PR Newswire
13/06/2024
Body Composition Analyzers Market: USD 1.2B by 2029, 9.3% CAGR Boosted by Health…
Browse in-depth TOC on "Body Composition Analyzers Market" Browse in-depth TOC on "Body Composition Analyzers Market" 366 - Tables 42 - Figures 294 - Pages Driving Force: Rising Prevalence of Obesity-Related Disorders The escalating rates of obesity and associated metabolic disorders are propelling the demand for body composition analyzers. These devices offer detailed insights crucial for diagnosing and managing conditions like diabetes and cardiovascular diseases...
PR Newswire
13/06/2024
Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China
Mesalazine is a medication used to treat Inflammatory Bowel Diseases (IBD) such as ulcerative colitis and Crohn's disease. Mesalazine is a medication used to treat Inflammatory Bowel Diseases (IBD) such as ulcerative colitis and Crohn's disease. Since 1997, Ethypharm has pioneered the Chinese Mesalazine oral market with Etiasa®, achieving approximately 30% market share. Chinais the third-largest market of Mesalazine globally, with mainly oral forms and topical forms accounting for 20%...
PR Newswire
13/06/2024
Livestock Diagnostics Market to be Worth $2.56 billion in 2031- Exclusive Report…
Livestock diagnostics play an important role in monitoring the health status of livestock animals and identifying pathogens. It is also used for the early detection, management, and control of livestock diseases, including zoonosis. This process further facilitates the safe trade of animals and animal-derived products. Thus, livestock diagnosis has emerged as an essential part of animal disease management and prevention. Livestock diagnostics play an important role in monitoring the health...
PR Newswire
13/06/2024
SKAN Research Trust and Quadram Institute Bioscience to Develop Novel Microbial…
The joint study titled the Application of TraDIS-Xpress in Microbiology for Healthy Living will be led by Quadram Principal Investigator, Prof. Mark Webber and SKAN's Deputy Director, Dr Yogesh Shouche. The project is part of a larger Comprehensive Partnership Agreement between the two organizations that have ongoing international collaborations focused on gut health and developing gut microbial therapies to alleviate ageing and neurological diseases like Parkinsons. The joint study titled…
PR Newswire
13/06/2024
Resolution Therapeutics to Host Virtual R&D Webinar on Liver Disease with World…
The event will feature an in-depth update on the clinical data from the extended MATCH Phase 2 clinical study and provide insight on Resolution's novel discovery platform for engineered macrophage cell therapy to enhance therapeutic efficacy in end-stage liver disease (ESLD). Poster presentations on these data were presented at the EASL Congress 2024, held in Milan between 5-8 June 2024. The event will feature an in-depth update on the clinical data from the extended MATCH Phase 2 clinical...
PR Newswire
13/06/2024
SciBase strengthens the US organization with experienced leader in dermatology
Her expertise spans startup environments and the successful launches of products at renowned companies including Aventis, Amgen, Arthrex and DermTech. Leda has concentrated her efforts in the field of dermatology. Her experience in launching and driving sales of new products and technologies, building winning teams in the US dermatology market as well as experience in cost reimbursement in the US, will be key to driving SciBase US sales and market establishment forward. Her expertise spans...
PR Newswire
13/06/2024
Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen
As a bioequivalent version of Victoza ®pre-filled pen, indicated for the treatment of type 2 diabetes, this peptide drug achieved global sales exceeding $4.8 billion in 2023, as reported by IQVIA. The successful development of Liraglutide highlights Adalvo's capability to offer a diverse and comprehensive diabetes portfolio, encompassing both complex peptide injectables and small molecule oral treatments. Adalvo's commitment to providing access to high-quality differentiated products...
Nasdaq GlobeNewswire
13/06/2024
Idorsia holds its Annual General Meeting of Shareholders
All Board proposals approved by the shareholdersAllschwil, Switzerland – June 13, 2024At today's Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted in favor of all proposals by the Board of Directors with very large majorities.The meeting was attended by 201 shareholders, representing a total of 90,297,668 shares, or 47.78% of the total outstanding shares.Led by the Chairman of the Board, Mathieu Simon, and Jean-Paul Clozel, who...
Nasdaq GlobeNewswire
13/06/2024
Amplify Healthcare Documentation: New AI-Powered Clinical Workflow Solution…
Prescribe Digital has supported clinicians with documentation in the healthcare industry for almost 20 years. This solution comes as a new arm to their support offering, providing clinicians and administrative staff with tools to help revolutionise workflows. Prescribe Digital has supported clinicians with documentation in the healthcare industry for almost 20 years. This solution comes as a new arm to their support offering, providing clinicians and administrative staff with tools to help...
PR Newswire
13/06/2024
Xeltis receives IDE approval from FDA for initiation of US pivotal trial for…
Xeltis' groundbreaking implants platform is an important development in vascular replacement technology as, over time, its implants are gradually replaced by the patients' own living healthy tissue. Xeltis' novel technology has already treated over 100 patients across different clinical trials. Xeltis' groundbreaking implants platform is an important development in vascular replacement technology as, over time, its implants are gradually replaced by the patients' own living healthy tissue...
PR Newswire
13/06/2024
Roborock Unveils Roborock Qrevo Master - A Powerful Self-Cleaning Robotic Vacuum…
"The Roborock Qrevo Master represents a significant leap forward in robotic cleaning technology," said Mr. Quan, Roborock President. "Offering unparalleled cleaning performance and a seamless user experience, the Roborock Qrevo Master delivers elite cleaning at an accessible price point." "The Roborock Qrevo Master represents a significant leap forward in robotic cleaning technology," saidMr. Quan, Roborock President. "Offering unparalleled cleaning performance…
PR Newswire
13/06/2024
Altri Comunicati
